Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Autor: Dixon, Barry *, Smith, Roger J, Campbell, Duncan J, Moran, John L, Doig, Gordon S, Rechnitzer, Thomas, MacIsaac, Christopher M, Simpson, Nicholas, van Haren, Frank M P, Ghosh, Angajendra N, Gupta, Sachin, Broadfield, Emma J C, Crozier, Timothy M E, French, Craig, Santamaria, John D
Zdroj: In The Lancet Respiratory Medicine April 2021 9(4):360-372
Databáze: ScienceDirect